Research Use Only
"Research Use Only" (RUO) is a regulatory label for a laboratory product or chemical that may be used only for laboratory research. It means the product or chemical has not been approved or validated by the FDA for clinical, diagnostic, or human use.
Also called: RUO, For Research Use Only
Research Use Only (RUO) is an FDA labeling designation for laboratory-stage products. The label must state, "For Research Use Only. Not for use in diagnostic procedures." RUO controls intended use, not purity, safety, or clinical suitability.
Research Use Only applies to laboratory tools and peptides
Research Use Only (RUO) applies to analytical tools, research chemicals, and peptides intended for non-clinical laboratory experiments. Because these products are in the research phase, they are exempt from FDA premarket clearance. This means RUO products lack FDA-validated clinical performance characteristics, such as accuracy or precision. On a lab report or Certificate of Analysis (CoA), RUO means the testing methods do not have FDA-validated clinical reliability.
Common misunderstandings regarding the RUO designation
- RUO on a lab report or Certificate of Analysis (CoA) does not certify safety, purity, pharmaceutical grade, or human use.
- FDA judges true intended use from all evidence, including marketing claims, not the RUO wording alone.
- Human-use marketing, such as claims about muscle building or weight loss, can make an RUO product an unapproved new drug.
- RUO differs from Investigational Use Only (IUO): RUO covers early lab development, while IUO relates to later clinical trial phases.
- RUO is not a legal loophole for selling products for consumption; FDA rejects that use through enforcement actions.
Sources
- Types of in Vitro Diagnostics: Clearing up the Confusion
- Distribution of In Vitro Diagnostic Products Labeled for Research ...
- [PDF] Draft Guidance for Industry and FDA Staff - Commercially Distributed ...
- FDA status of research compounds: IND, NDA, and the IRB pathway | Compound Review
- Definitions and General Oversight: Laboratory Developed Tests FAQs | FDA
- FDA Warning Letter Is a Stark Reminder That If You Claim ... - Mintz
- FDA Targets GLP-1 and Peptide Compounding, Advertising and ‘Research Use Only’ Labeling | Health Law Alliance
- Gram Peptides - 721806 - 03/31/2026 | FDA
- USApeptide.com - 696885 - 02/26/2025 | FDA
- The 'Research Use Only' Loophole Just Closed: FDA Hits Seven Peptide Websites in a Single Day | Policy Canary
- Laboratory-developed tests and in vitro diagnostics: A regulatory overview for anatomic pathology
- FDA panel on peptides will include experts who promote the unproven chemicals favored by RFK Jr. | PBS News
- In Vitro Diagnostic Device Labeling Requirements | FDA
- Research Use Only (RUO): FDA Regulations and Labeling - LegalClarity
- Draft Guidance for Industry and Food and Drug Administration Staff
- Lovega LLC dba Pink Pony Peptides
- FDA "Research Use Only" Crackdown: April 2026 Letters